Alpha Tau Medical Ltd (DRTS) has a current Price-to-Book (P/B) ratio of 5.31. Compared to its 3-year average P/B ratio of 2.75, the current P/B ratio is approximately 93.02% higher. Relative to its 5-year average P/B ratio of -1.94, the current P/B ratio is about -374.21% higher. Alpha Tau Medical Ltd (DRTS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.77%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -4.75%, the current FCF yield is about -100.00% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for DRTS competitors is 169.50, providing a benchmark for relative valuation. Alpha Tau Medical Ltd Corp (DRTS.O) exhibits a P/S ratio of 652.66, which is 285.04% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of DRTS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of DRTS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is DRTS currently overvalued or undervalued?

What is Alpha Tau Medical Ltd (DRTS) fair value?

DRTS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Alpha Tau Medical Ltd (DRTS) is between 2.40 to 14.17 according to relative valuation method.

How does DRTS's valuation metrics compare to the industry average?

The average P/S ratio for DRTS's competitors is 169.50, providing a benchmark for relative valuation. Alpha Tau Medical Ltd Corp (DRTS) exhibits a P/S ratio of 652.66, which is 285.04% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Alpha Tau Medical Ltd (DRTS) as of Mar 04 2026?

As of Mar 04 2026, Alpha Tau Medical Ltd (DRTS) has a P/B ratio of 5.31. This indicates that the market values DRTS at 5.31 times its book value.

What is the current FCF Yield for Alpha Tau Medical Ltd (DRTS) as of Mar 04 2026?

As of Mar 04 2026, Alpha Tau Medical Ltd (DRTS) has a FCF Yield of 0.00%. This means that for every dollar of Alpha Tau Medical Ltd's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Alpha Tau Medical Ltd (DRTS) as of Mar 04 2026?

As of Mar 04 2026, Alpha Tau Medical Ltd (DRTS) has a Forward P/E ratio of -9.99. This means the market is willing to pay $-9.99 for every dollar of Alpha Tau Medical Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Alpha Tau Medical Ltd (DRTS) as of Mar 04 2026?

As of Mar 04 2026, Alpha Tau Medical Ltd (DRTS) has a Forward P/S ratio of 652.66. This means the market is valuing DRTS at $652.66 for every dollar of expected revenue over the next 12 months.

DRTS Valuation